Activation of PLCβ1 enhances endocannabinoid mobilization to restore hippocampal spike-timing-dependent potentiation and contextual fear memory impaired by Alzheimer’s amyloidosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Activation of PLCβ1 enhances endocannabinoid mobilization to restore hippocampal spike-timing-dependent potentiation and contextual fear memory impaired by Alzheimer’s amyloidosis ; volume:13 ; number:1 ; day:8 ; month:10 ; year:2021 ; pages:1-16 ; date:12.2021
Alzheimer's research & therapy ; 13, Heft 1 (8.10.2021), 1-16, 12.2021
- Creator
-
Lee, Jaedong
Kwag, Jeehyun
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-021-00901-9
- URN
-
urn:nbn:de:101:1-2021122507480996376558
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lee, Jaedong
- Kwag, Jeehyun
- SpringerLink (Online service)
Other Objects (12)
Remodeling Alzheimer-amyloidosis models by seeding
Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis
Microglial CD2AP deficiency exerts protection in an Alzheimer’s disease model of amyloidosis
Cellular mechanism of amyloid formation in Alzheimer’s disease and systemic AA amyloidosis
Beyond genetics: including the environmental dimension in amyloidosis mouse models for Alzheimer’s disease
Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration
Cathepsin B Improves ß-Amyloidosis and Learning and Memory in Models of Alzheimer’s Disease
Dopamine–endocannabinoid interactions mediate spike-timing-dependent potentiation in the striatum
Sex-specific hypothalamic neuropathology and glucose metabolism in an amyloidosis transgenic mouse model of Alzheimer’s disease
Alzheimer’s Disease
Effects of SPI1-mediated transcriptome remodeling on Alzheimer’s disease-related phenotypes in mouse models of Aβ amyloidosis
Remodeling Alzheimer-amyloidosis models by seeding
Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis
Microglial CD2AP deficiency exerts protection in an Alzheimer’s disease model of amyloidosis
Cellular mechanism of amyloid formation in Alzheimer’s disease and systemic AA amyloidosis
Beyond genetics: including the environmental dimension in amyloidosis mouse models for Alzheimer’s disease
Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration
Cathepsin B Improves ß-Amyloidosis and Learning and Memory in Models of Alzheimer’s Disease
Dopamine–endocannabinoid interactions mediate spike-timing-dependent potentiation in the striatum
Sex-specific hypothalamic neuropathology and glucose metabolism in an amyloidosis transgenic mouse model of Alzheimer’s disease
Alzheimer’s Disease
Effects of SPI1-mediated transcriptome remodeling on Alzheimer’s disease-related phenotypes in mouse models of Aβ amyloidosis
Remodeling Alzheimer-amyloidosis models by seeding
Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis
Microglial CD2AP deficiency exerts protection in an Alzheimer’s disease model of amyloidosis
Cellular mechanism of amyloid formation in Alzheimer’s disease and systemic AA amyloidosis
Beyond genetics: including the environmental dimension in amyloidosis mouse models for Alzheimer’s disease
Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration
Cathepsin B Improves ß-Amyloidosis and Learning and Memory in Models of Alzheimer’s Disease
Dopamine–endocannabinoid interactions mediate spike-timing-dependent potentiation in the striatum
Sex-specific hypothalamic neuropathology and glucose metabolism in an amyloidosis transgenic mouse model of Alzheimer’s disease
Alzheimer’s Disease